CD8A and cancer: Based on evaluation standards from multiple layers, W-GTF01 (No.8 compound) was confirmed as a potent inhibitor of MGAT1 activity and stimulator of CD8+ IFNγ-producing T-cell response, leading to lowest cancer cell survival.